Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Thomas BüttnerFlorian GärtnerMarkus EsslerRichard WeitenGlen KristiansenJoerg EllingerManuel RitterPhilipp KrausewitzPublished in: The Prostate (2024)
While PET-TB can simplify prostate biopsy and reduce invasiveness by core number, SB cannot be omitted yet due to potential PET-TB targeting errors. Factors such as limited spatial resolution and fusion inaccuracies contribute to the need for SB. Standardization in reporting schemes currently cannot compensate for targeting errors highlighting the need for refinement.
Keyphrases
- positron emission tomography
- computed tomography
- prostate cancer
- benign prostatic hyperplasia
- pet ct
- cancer therapy
- pet imaging
- mycobacterium tuberculosis
- adverse drug
- ultrasound guided
- magnetic resonance imaging
- patient safety
- drug delivery
- magnetic resonance
- contrast enhanced
- image quality
- climate change
- quality improvement